Night Sleep Architecture and Rhythmic Movement Disorder
Rhythmic movement disorder is a rare motor disorder that results in frequent night sleep disturbances.
Sleep Disorders
Insomnia and Alcohol Consumption Linked to ADHD Symptoms
Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.
Acupuncture Improves Sleep, Melatonin Levels in Pregnancy-Related Insomnia
Nearly half of pregnant women suffer from poor quality sleep, particularly in the third trimester, and poor sleep is associated with an increased risk of preterm delivery and postnatal depression.
Exploring the Link Between Pediatric Migraine & Sleep Disorders
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Dayvigo Now Available for Insomnia Treatment
Dayvigo (lemborexant; Eisai) is now available for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients.
Sleep Problems in Infancy May Be Tied to Autism Diagnosis
Sleep-onset problems in the first year of life may precede an autism spectrum disorder diagnosis in children at higher risk for ASD.
Improvement of Sleep Apnea and Sleep Patterns May Improve Glycemic Control in Black Patients
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
Light Therapies Feature Low Attrition and Relatively High Acceptance, Despite Research Drawbacks
While carefully timed light exposure may address sleep problems associated with circadian rhythm disturbances, studies that examine light therapies in the context of sleep disorders have been largely lacking in measures of adherence and acceptability of these approaches.
Insomnia Common Among Medical Staff During COVID-19 in China
More than one-third of medical staff members in hospitals during the COVID-19 outbreak in China reported insomnia symptoms.
Daridorexant Improves Sleep, Daytime Performance in Insomnia Study
Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.
-
Loading...
-
Loading...
Next post in Sleep Information Center
